Figma and Anthropic are partnering on AI coding tools that integrate Claude Code. Software stocks have sold off as AI tools threaten to upend the industry. Figma reports earnings Wednesday. The stock ...

Work is full of time-sucking, tedious or annoying tasks, particularly when you’re on a computer. I used to spend hours on stupid chores like reorganizing someone else’s messy spreadsheet. Now, I use ...

An emergent ransomware group has put a new spin on the technique known as bring-your-own-vulnerable-driver (BYOVD). In a report published Thursday, the Symantec and Carbon Black Threat Hunter Team ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Microsoft-owned GitHub continues to embrace OpenAI and Anthropic AI advances. Microsoft-owned GitHub continues to embrace OpenAI and Anthropic AI advances. is a senior editor and author of Notepad, ...

Waseem is a writer here at GameRant. He can still feel the pain of Harry Du Bois in Disco Elysium, the confusion of Alan Wake in the Remedy Connected Universe, the force of Ken's shoryukens and the ...

Tender Crimson Stone will come in multiple tiers, but how to get them all is pretty much the same. The first place to look for the item is from one of Jadwiga's Minions. These odd-looking shopkeepers ...

GameSpot may get a commission from retail offers. Code Vein 2 features three different endings, but unlike many similar games, they don't require you to enter New Game Plus to access them. Instead, ...

Engineers in Silicon Valley have been raving about Anthropic’s AI coding tool, Claude Code, for months. But recently, the buzz feels as if it’s reached a fever pitch. Earlier this week, I sat down ...

The Winter Expansion Part 1 update added a few new races to The Forge, with a popular one called the Archangel. Some rumors around the community had players wondering if you need to have both the ...

Antibody drug conjugates (ADCs) mark a new era in targeted cancer therapy, delivering potent cytotoxic chemotherapy via monoclonal antibodies directly into the tumor cells — an era with potentially ...